The Evolving Landscape of Prescription Eyewear and Diagnostic Instruments in the U.S.
The U.S. ophthalmic spectacle lenses and equipment market, valued at USD 19.15 billion in 2024 and expected to grow at a CAGR of 5.6% through 2034, is undergoing a structural transformation driven by innovation in product segmentation and evolving consumer behavior. Growth is increasingly concentrated in high-value categories such as progressive addition lenses (PALs), photochromic lenses, and...
0 Комментарии 0 Поделились 88 Просмотры 0 предпросмотр